Scotiabank’s $33 target on PFE

PFE Pfizer

$27.5 → $33 (+20%) by Oct 2027

Sector Outperform · raises · said Oct 6, 2026 · 12-month default horizon

Open: judged on the close on Oct 6, 2027

The article this target came from

PFE Maintained by Scotiabank -- Price Target Raised to $33.00

GuruFocus · Oct 6, 2026

On October 6, 2026, Scotiabank maintained a Sector Outperform rating for Pfizer (PFE), raising the price target from $30.00 to $33.00

Scotiabank’s track record → Pfizer →

A fact about what Scotiabank published, as reported by GuruFocus, not a recommendation from Dalsna Finance; Scotiabank is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.